Search clinical trials for: Ceritinib (LDK378)
Total 495 results
-
Novartis PharmaceuticalsCompletedNon-Small-Cell Lung CancerJapan
-
Novartis PharmaceuticalsAvailableNon-small Cell Lung Cancer (NSCLC) | Anaplastic Lymphoma Kinase (ALK)- Positive Tumors
-
Novartis PharmaceuticalsCompletedNon-Small Cell Lung CancerCanada, Taiwan, United States, Italy, Korea, Republic of, Thailand, Belgium, Germany, Austria, Turkey, Greece, United Kingdom, Colombia, India, Malaysia, Brazil, Spain, Poland, Bulgaria, Australia, Czechia, Lebanon, Netherlands, Russian...
-
Novartis PharmaceuticalsTerminatedGlioblastoma | Anaplastic Large Cell Lymphoma | Inflammatory Myofibroblastic Tumor | Tumors With Aberrations in ALKFrance, Czechia, Italy, Spain, Korea, Republic of, Thailand, Israel, Denmark
-
Anne Beaven, MDNovartisWithdrawnHematologic MalignanciesUnited States
-
Yonsei UniversityUnknownNon-small Cell Lung Cancer Harboring ROS1 RearrangementKorea, Republic of
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; National Cheng-Kung University HospitalTerminated
-
Novartis PharmaceuticalsCompletedTumors Characterized by Genetic Abnormalities of ALKAustralia, Belgium, Germany, Netherlands, Spain, Italy, Singapore, Korea, Republic of, United Kingdom, United States, Canada
-
Novartis PharmaceuticalsCompletedNon-Small Cell Lung CancerCanada, Italy, United Kingdom, Spain, Netherlands, Singapore, Germany, Hong Kong, Japan, France, Korea, Republic of, United States
-
Novartis PharmaceuticalsNo longer availableNon-small Cell Lung Cancer (NSCLC)United States, Argentina, Korea, Republic of, Hong Kong, Thailand, Mexico, Jordan, Colombia, India, Philippines
-
Novartis PharmaceuticalsCompletedALK-activated TumorsFrance, Spain, Germany, Italy, Korea, Republic of, Canada, Australia, United Kingdom, Netherlands, United States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedNormal Hepatic Function | Impaired Hepatic FunctionUnited States
-
Novartis PharmaceuticalsCompletedNon-Small Cell Lung CancerUnited Kingdom, Taiwan, Belgium, Spain, Canada, Italy, Singapore, Japan, Russian Federation, Hong Kong, Thailand, Korea, Republic of, Norway, Australia, France, Sweden, United States, New Zealand
-
Novartis PharmaceuticalsActive, not recruitingALK-positive NSCLCBelgium, Spain, Italy, Australia, United States, Hong Kong, Canada, Singapore
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung Cancer | Anaplastic Lymphoma Kinase (ALK)Australia, Spain, Singapore, Italy, United States
-
Novartis PharmaceuticalsTerminatedCeritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE) (SIGNATURE)Tumors With Aberrations in ALK or ROS1United States
-
Novartis PharmaceuticalsCompletedTumors Characterized by Genetic Alterations in Anaplastic Lymphoma Kinase (ALK)Japan
-
Yonsei UniversityUnknownNon-small Cell Lung Cancer (NSCLC)Korea, Republic of
-
Novartis PharmaceuticalsCompletedALK-positive Non-small Cell Lung CancerUnited States, France, Italy, United Kingdom, Taiwan, Turkey, Belgium, Germany, Canada, Singapore, Spain, Korea, Republic of, Netherlands, Russian Federation, Brazil, Hong Kong, Australia
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerTaiwan, Spain, Italy, United States, Korea, Republic of, France
-
Novartis PharmaceuticalsCompletedAdenocarcinoma Lung Cancer; Squamous Cell Lung CarcinomaChina
-
Novartis PharmaceuticalsCompletedNon-Small Cell Lung CancerItaly, Spain, Taiwan, Germany, Netherlands, Singapore, Austria, Japan, Australia, France, Russian Federation, Sweden, Thailand, Korea, Republic of, Lebanon, Norway, United Kingdom, China, India, Brazil, Turkey, Poland, Denmark, Greece, ... and more
-
University of California, San FranciscoTerminatedALK Fusion Protein Expression | Stage III Cutaneous Melanoma | Stage IIIA Cutaneous Melanoma | Stage IIIB Cutaneous Melanoma | Stage IIIC Cutaneous Melanoma | Stage IV Cutaneous Melanoma | ROS1 Fusion Positive | BRAF wt Allele | Invasive Skin Melanoma | MET Fusion Gene Positive | NRAS wt Allele | NTRK1 Fusion... and other conditionsUnited States
-
St. Joseph's Hospital and Medical Center, PhoenixNovartis; Wayne State University; Translational Genomics Research InstituteCompletedGlioblastoma | Brain MetastasesUnited States
-
Novartis PharmaceuticalsRecruitingALK Positive MalignanciesGermany, France, Australia, Belgium, Italy, Korea, Republic of, Poland, China, United States, Taiwan, Brazil, Bulgaria, Hong Kong, Japan, Lebanon, Malaysia, Spain, Russian Federation, Colombia, Singapore, Czechia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | ROS1 Gene Rearrangement | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | ALK PositiveUnited States
-
Criterium, Inc.University of Colorado, Denver; NovartisTerminatedPancreatic Adenocarcinoma | Gastric Adenocarcinoma | Cholangiocarcinoma | Esophageal Adenocarcinoma | Colorectal Adenocarcinoma | Hepatocellular AdenocarcinomaUnited States
-
Sun Yat-sen UniversityUnknown
-
Yael P MosseNovartis Pharmaceuticals; Foundation MedicineTerminated
-
PfizerRecruitingNon-Small Cell Lung CancerNorway
-
Pierre Fabre MedicamentNot yet recruiting
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Completed
-
UNC Lineberger Comprehensive Cancer CenterNo longer available
-
Pierre Fabre Pharma GmbHiOMEDICO AG; Pierre Fabre Pharma Austria; Pierre Fabre Pharma AGActive, not recruiting
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Withdrawn
-
Convalife (Shanghai) Co., Ltd.Not yet recruiting
-
Qilu Pharmaceutical Co., Ltd.UnknownNon-small-cell Lung CancerChina
-
Hutchison Medipharma LimitedUnknown
-
Sun Yat-sen UniversityWu Jieping Medical FoundationCompletedNon-small Cell Lung CancerChina
-
Shanghai Fosun Pharmaceutical Industrial Development...RecruitingAdvanced Solid Tumor | Advanced Cancer | Lung Cancer, Nonsmall CellChina
-
Jiangsu Famous Medical Technology Co., Ltd.UnknownNon-small Cell Lung Cancer
-
AstraZenecaCompletedNeoplasms, Squamous CellUnited States, Czech Republic, Poland, Germany, Belgium, Taiwan, India, Serbia
-
Hutchison Medipharma LimitedCompleted